ABBV
AbbVie Inc.
Balance sheet
| USDLine, in USD | Q3 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | 5.3B | 5.6B | 12.8B | 9.2B | 9.8B | 8.5B | 39.9B | 8.1B | 9.8B | 6.4B | 8.4B | 8.4B | 9.9B | 8.0B | — | |
Inventory | 5.31B | 4.95B | 4.18B | 4.10B | 3.58B | 3.13B | 3.31B | 1.81B | 1.61B | 1.61B | 1.44B | 1.72B | 1.12B | 1.15B | 1.09B | — |
| Current assets | 37.5B | 29.1B | 25.6B | 33.0B | 28.5B | 27.9B | 24.2B | 49.5B | 16.9B | 21.2B | 16.2B | 16.3B | 16.1B | 17.8B | 15.4B | — |
Goodwill | 37.8B | 35.6B | 35.0B | 32.3B | 32.2B | 32.4B | 33.1B | 15.6B | 15.7B | 15.8B | 15.4B | 13.2B | 5.9B | 6.3B | 6.1B | 6.1B |
Intangible assets | 56.7B | 52.6B | 60.1B | 55.6B | 67.4B | 76.0B | 82.9B | 18.6B | 21.2B | 27.6B | 28.9B | 19.7B | 1.5B | 1.9B | 2.3B | — |
| Total assets | 147.7B | 134.0B | 135.2B | 134.7B | 138.8B | 146.5B | 150.6B | 89.1B | 59.4B | 70.8B | 66.1B | 53.1B | 27.5B | 29.2B | 27.0B | — |
Current liabilities | 43.1B | 43.3B | 38.7B | 37.8B | 29.5B | 35.2B | 28.7B | 15.6B | 17.2B | 16.6B | 9.8B | 10.9B | 11.4B | 6.9B | 6.8B | — |
| 72.2B | 64.5B | 66.8B | 59.2B | 63.1B | 76.0B | 84.9B | 67.2B | 35.0B | 31.0B | 36.4B | 29.2B | 10.5B | 14.3B | 14.6B | — | |
| Total liabilities | 152.2B | 137.2B | 131.8B | 124.3B | 121.5B | 131.1B | 137.5B | 97.3B | 67.8B | 65.7B | 61.5B | 49.1B | 25.8B | 24.7B | 27.4B | — |
| Shareholders' equity | −4.6B | −3.3B | 3.3B | 10.4B | 17.3B | 15.4B | 13.1B | −8.2B | −8.4B | 5.1B | 4.6B | 3.9B | 1.7B | 4.5B | −350M | — |
| Shares outstanding | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.48B | 1.48B | 1.59B | 1.59B | 1.61B | 1.59B | 1.59B | — | — |
| Current ratio | 0.87 | 0.67 | 0.66 | 0.87 | 0.96 | 0.79 | 0.84 | 3.18 | 0.98 | 1.28 | 1.65 | 1.50 | 1.41 | 2.59 | 2.27 | — |